Description

Zucarb (Carboplatin Injection) – Product Description Zucarb contains Carboplatin, a prescription platinum-based chemotherapy medicine used in the treatment of various solid tumors, including ovarian cancer, lung cancer, head and neck cancer, and other malignancies. It belongs to the platinum-containing antineoplastic agents and works by damaging the DNA of cancer cells, preventing their growth and division, ultimately leading to cancer cell death. Zucarb is administered as an intravenous (IV) infusion by qualified healthcare professionals. It may be used alone or in combination with other chemotherapy medicines depending on the type and stage of cancer, as well as the patient's overall treatment plan. Active Ingredient Carboplatin Dosage Form Sterile Injection for Intravenous (IV) Infusion Therapeutic Indications Ovarian Cancer Non-Small Cell Lung Cancer (NSCLC) Small Cell Lung Cancer (SCLC) Head and Neck Cancer Endometrial Cancer Other solid tumors as recommended by the treating oncologist How It Works Carboplatin forms DNA cross-links within cancer cells, preventing DNA replication and repair. This disrupts cell division and triggers the death of rapidly dividing cancer cells, helping to slow or stop tumor growth. Key Features Platinum-based chemotherapy with proven clinical efficacy Effective against a wide range of solid tumors Suitable for use as monotherapy or combination chemotherapy Administered under specialist oncology supervision Manufactured according to stringent pharmaceutical quality standards Storage Store according to the manufacturer's recommendations. Protect from excessive heat, freezing, and direct light. Keep out of reach of children. Note: Zucarb (Carboplatin Injection) is a prescription-only chemotherapy medicine and should only be administered by qualified healthcare professionals experienced in oncology. Regular monitoring of blood counts, kidney function, liver function, andelectrolyte levels is recommended throughout treatment.